ESTRO 36 Programme book and exhibition guide

09:39 > Can we perform RCTs evaluating MR guided radiotherapy? Speaker: V. Valentini (Italy)

SP-0396

MONDAY 8 MAY 2017

SYMPOSIUMWITH PROFFERED PAPERS Novel approaches in head and neck tumour control 08:45 - 10:00 | LEHAR 4 Chair: R. Suwinski (Poland) Co-chair: A. Schratter-Sehn (Austria) 08:45 > State of the art in head and neck tumour radiobiology B. O’Sullivan (Canada)

SP-0397

09:12 > Novel developments in the radiobiology of HPV-positive head and neck tumours S. Nuyts (Belgium) 09:39 > Transcriptome analyses of the radiation response in HNSCC cells with different radiation sensitivity J. Heß (Germany), A. Michna, U. Schötz, M. Selmansberger, H. Zitzelsberger, K. Unger, K. Lauber 09:49 > Prognostic impact of tumor infiltrating lymphocytes and PD-L1 expression in head and neck cancers

SP-0398

OC-0399

D. Ou (France), J. Adam, I. Garberis, P. Blanchard, F. Nguyen, A. Levy, O. Casiraghi, P. Gorphe, I. Breuskin, F. Janot, S. Temam, J. Scoazec, E. Deutsch, Y. Tao

OC-0400

SYMPOSIUM Experimental therapies 08:45 - 10:00 | STRAUS 2-3

This session deals with two treatment modifiers and a verification technique based on Cerenkov radiation. This radiation is emitted when particles pass through tissue exceeding the speed of light and may be used for QA and real time in vivo dosimetry. Gold nanoparticles tend to have selective uptake in tumours and can be used as photothermal agent or to enhance local delivery of dose. In grid therapy, dose is spatially modulated. As hypofractionated boost this was effective in small clinical series. Its big advantage is reduced toxicity, and the main interest has been in bulky tumours and palliation. Chair: M. Van Herk (UK) Co-chair: F. Mahmood (Denmark)

08:45 > Grid therapy: past, present, and future Speaker: A. Siegbahn (Sweden)

SP-0401

SCIENTIFIC PROGRAMME | Programme and Exhibition Guide

130